KRAS G12C
KRAS G12C is a significant oncogenic mutation linked to various cancers. Targeted therapies offer promising treatment options. Discover innovative solutions and improve patient outcomes by exploring cutting-edge research. Act now to learn more about KRAS G12C inhibitors and their potential in cancer care.
Showing all 9 results
- Sale!
Lung cancer600mg Adagrasib Capsules $250
Original price was: $188.00.$29.00Current price is: $29.00. - Sale!leukemia
Adagrasib 200mg Capsules for NSCLC KRAS G12C India
Original price was: $198.00.$39.00Current price is: $39.00. - Sale!Esophageal Cancer
Adagrasib 200mg Tablets in India for KRAS G12C NSCLC
Original price was: $198.00.$39.00Current price is: $39.00. - Sale!Esophageal Cancer
Adagrasib 600 mg NSCLC KRAS G12C Treatment in India
Original price was: $197.00.$38.00Current price is: $38.00. - Sale!
- Sale!leukemia
Adagrasib 600mg Tabs KRAS G12C Inhibitor for India
Original price was: $185.00.$26.00Current price is: $26.00. - Sale!Kidney Cancer
Generic Adagrasib KRAS G12C Cancer Med 200mg Tab
Original price was: $197.00.$38.00Current price is: $38.00. - Sale!Esophageal Cancer
Generic KRAS G12C NSCLC Inhibitor Tablets
Original price was: $187.00.$28.00Current price is: $28.00. - Sale!Brain Cancer
KRAS G12C InhibGenericNSCLC
Original price was: $195.00.$36.00Current price is: $36.00.
